Showing results (91-100 of 233) with videos related to
Sort By:
Pageof 24
Journal of the Neurological Sciences|September 1, 1990
Determination of manganese concentrations in the spinal cords from amyotrophic lateral sclerosis patients by inductively coupled plasma emission spectroscopyT Kihira, M Mukoyama, K Ando, et al.Cancer|December 15, 1987
Carcinoembryonic antigen estimation in nipple discharge as an adjunctive tool in the diagnosis of early breast cancerH Inaji, E Yayoi, Y Maeura, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Intra-arterial infusion chemotherapy in the treatment of advanced breast cancer--doxorubicin versus epirubicin]E Yayoi, J Furukawa, Y Takatsuka, et al.Surgery Today|January 1, 1992
Multiple colorectal carcinomas and colorectal carcinoma associated with extracolonic malignanciesH Maruyama, Y Hasuike, J Furukawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 16, 2001
[A case of locally advanced breast cancer treated with hyperthermia in combination with radiotherapy]M Yamasaki, E Yayoi, M Kishibuchi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1989
[Prognostic significance of intra-arterial infusion chemotherapy in the treatment of locally advanced breast cancer]E Yayoi, H Maruyama, N Takata, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
Follow-up study of combination treatment (TAE and PEIT) for unresectable hepatocellular carcinomaH Tateishi, M Kinuta, J Furukawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1997
[A comparative study between low-dose and high-dose medroxyprogesterone acetate (MPA) in the treatment of advanced and recurrent breast cancer--in relation to dose, serum concentration and response. Osaka Breast Cancer Research Group]J Furukawa, E Yayoi, Y Takatsuka, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1995
[A comparison of intra-arterial chemoembolization and infusion chemotherapy for liver metastases of breast cancer]E Yayoi, J Furukawa, M Sekimoto, et al.Journal of Clinical & Laboratory Immunology|December 1, 1986
Induction of tumor necrosis factor by administration of OK-432 in cancer patientsI Kokunai, T Shimano, K Sekimoto, et al.Pageof 24